Mequon, Wis.-based Titan Spine named Ted Bird its next Chief Commercial Officer.
Spinal Tech
Castel San Pietro, Switzerland-based Medacta showcased its new MasterLoc Hip System and GMK Sphere Knee at the 26th American Association of Hip and Knee Surgeons Annual Meeting.
Dublin, Ireland-based Medtronic unveiled its new business unit, which will offer joint-replacement products, according to Minneapolis/St. Paul Business Journal.
Pan Medical Corporation, (www.panmed.us) specializing in the creation and development of cutting edge products, is glad to announce 510(k) approval for the InterV Flex and InterV Mico vertebral augmentation systems.
Flexion Therapeutics' lead investigational product candidate Zilretta, also known as FX006, demonstrated clinically and statistically significant improvement in a Phase III trial for patients with knee osteoarthritis.
Here are nine key notes on orthopedic and spine device companies over the past week.
Swiss Federal Institute of Technology, Lausanne researchers created a new system for spinal cord injury therapy, wirelessly connecting the brain to the spinal cord below the injury, according to The New York Times.
The global minimally invasive neurosurgery devices market is expected to grow through 2025, according to a Future Market Insights report.
The internal watchdog at HHS allegedly told CMS that Canonsburg, Pa.-based Mylan Pharmaceuticals had been improperly classifying its EpiPen since 2009, Reuters reports.
Audubon, Pa.-based Globus Medical reported its third quarter 2016 financial results, according to The Cerbat Gem Market News and Analysis.
